Sector ratings Celltrion, Inc.

Stocks

End-of-day quote Korea S.E. Other stock markets 10/07/2026			5-day change	1st Jan Change
1,75,200.00 ^KRW	+1.21%		-4.58%	+1.64%

07/07	Celltrion Submits Amendment for Phase 3 Trial of Cancer Biosimilar to US FDA	MT
03/07	South Korean Shares Jump on Bargain-Hunting, Chip Stock Gains	MT

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Capi.($)	Investor	ESG MSCI	Fundamentals	Global Valuation
CELLTRION, INC.	2.63TCr		A
LONZA GROUP AG	5.04TCr		AAA
REVOLUTION MEDICINES, INC.	4.06TCr	-	B	-	-
IQVIA HOLDINGS INC.	3.49TCr		AAA
BEONE MEDICINES AG	3.37TCr		-
ASCENDIS PHARMA A/S	1.71TCr	-	-	-	-
MEDPACE HOLDINGS, INC.	1.53TCr		BBB
EUROFINS SCIENTIFIC SE	1.37TCr		AA
ICON PUBLIC LIMITED COMPANY	1.29TCr		AAA
ABIVAX	1.21TCr	-	BBB	-	-
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	1.13TCr		AA
BIO-TECHNE CORPORATION	1.11TCr		AA
TEMPUS AI, INC.	1.1TCr		A		-
IONIS PHARMACEUTICALS, INC.	1.06TCr	-	A	-	-
APOGEE THERAPEUTICS, INC.	1TCr	-	B	-	-
KYMERA THERAPEUTICS, INC.	978.87Cr	-	BBB	-	-
PRAXIS PRECISION MEDICINES, INC.	928.7Cr	-	B	-	-
ALKERMES PLC	896.38Cr		A
PROTAGONIST THERAPEUTICS, INC.	885.18Cr		BB		-
QIAGEN N.V.	868.36Cr		AAA
Average	1.78TCr		A
Weighted average by Cap.			A